文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性中补体表达的空间分布差异与改变

Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

该研究通过分析伴有和不伴有年龄相关性黄斑变性(AMD)的死后眼组织,检测补体mRNA和蛋白表达。发现黄斑区视网膜色素上皮(RPE)/脉络膜的补体表达水平比神经视网膜高约15至100倍,且地图样萎缩眼玻璃体和黄斑神经视网膜中补体水平轻度升高。结论提示RPE/脉络膜是眼部补体的主要来源,可能是补体抑制治疗的关键靶点。

要点

  • 黄斑区RPE/脉络膜的补体mRNA和蛋白水平比神经视网膜高约15至100倍。
  • 地图样萎缩眼的玻璃体和黄斑神经视网膜中补体水平轻度升高,而早期或中期AMD眼无此变化。
  • 地图样萎缩区域可见补体mRNA(C3、CFB、CFH、CFI、C1QA),C3 mRNA见于部分IBA1+小胶质细胞或巨噬细胞。

核心结论

  • RPE/脉络膜含有眼部大部分补体,而非神经视网膜或玻璃体,因此RPE/脉络膜可能是补体抑制治疗地图样萎缩或更早期AMD的关键部位。
  • 外视网膜局部产生补体mRNA并伴有补体激活增加的证据是地图样萎缩的特征。

研究设计与样本

  • 研究纳入了死后眼组织,根据眼底图像和H&E染色切片确定AMD严重程度分级1至4级。
  • 使用TaqMan(供体眼n=39)和RNAscope/原位杂交(n=10)检测补体mRNA。
  • 使用Meso Scale Discovery法和Western blot(n=31)测量补体蛋白水平。

主要发现

  • 无论AMD分级状态如何,黄斑区RPE/脉络膜组织中补体mRNA和蛋白表达水平比神经视网膜高约15至100倍(P < 0.0001-0.001)。
  • 与正常眼相比,地图样萎缩眼的玻璃体和黄斑神经视网膜中补体mRNA和蛋白水平轻度升高,但早期或中期AMD眼未见升高。
  • RNAscope检测显示替代途径和经典途径补体mRNA(C3、CFB、CFH、CFI、C1QA)在萎缩区域明显,且C3 mRNA见于部分IBA1+小胶质细胞或巨噬细胞。

临床怎么用

  • 补体抑制治疗AMD时,应优先靶向RPE/脉络膜而非神经视网膜或玻璃体。
  • 地图样萎缩区域存在局部补体mRNA产生和补体激活增加,提示针对局部补体活化的干预可能有益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dysregulation of the alternative complement pathway is a major pathogenic mechanism in age-related macular degeneration. We investigated whether locally synthesized complement components contribute to AMD by profiling complement expression in postmortem eyes with and without AMD. METHODS: AMD severity grade 1 to 4 was determined by analysis of postmortem acquired fundus images and hematoxylin and eosin stained histological sections. TaqMan (donor eyes n = 39) and RNAscope/in situ hybridization (n = 10) were performed to detect complement mRNA. Meso scale discovery assay and Western blot (n = 31) were used to measure complement protein levels. RESULTS: The levels of complement mRNA and protein expression were approximately 15- to 100-fold (P < 0.0001-0.001) higher in macular retinal pigment epithelium (RPE)/choroid tissue than in neural retina, regardless of AMD grade status. Complement mRNA and protein levels were modestly elevated in vitreous and the macular neural retina in eyes with geographic atrophy (GA), but not in eyes with early or intermediate AMD, compared to normal eyes. Alternative and classical pathway complement mRNAs (C3, CFB, CFH, CFI, C1QA) identified by RNAscope were conspicuous in areas of atrophy; in those areas C3 mRNA was observed in a subset of IBA1+ microglia or macrophages. CONCLUSIONS: We verified that RPE/choroid contains most ocular complement; thus RPE/choroid rather than the neural retina or vitreous is likely to be the key site for complement inhibition to treat GA or earlier stage of the disease. Outer retinal local production of complement mRNAs along with evidence of increased complement activation is a feature of GA.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Demirs JT, Yang J, Crowley MA, et al. Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2021. PMID: 34160562. doi:10.1167/iovs.62.7.26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。